{
 "PrintNo":"A5953","Session":2019,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2019-02-20T16:02:02.927222Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Alcoholism And Drug Abuse",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2020-01-08","Committee":"Alcoholism And Drug Abuse"}],
 "Actions":[
  {"Text":"REFERRED TO ALCOHOLISM AND DRUG ABUSE","Date":"2019-02-20","Chamber":"ASSEMBLY"},
  {"Text":"REFERRED TO ALCOHOLISM AND DRUG ABUSE","Date":"2020-01-08","Chamber":"ASSEMBLY"}
 ],
 "Sponsors":[{"ID":520,"Name":"Linda Rosenthal","Short":"ROSENTHAL L"}],
 "Title":"Relates to the availability of buprenorphine in opioid treatment programs",
 "Summary":"Requires all opioid treatment programs to have buprenorphine available for prescription to addicts.",
 "LawSection":"Mental Hygiene Law","LawCode":"Add ยง32.12, Ment Hyg L",
 "ActClause":"AN ACT to amend the mental hygiene law, in relation to the availability of buprenorphine in opioid treatment programs"
}